ArticlePharmaceuticals (Basel, Switzerland)2022

Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson's Disease via the Nrf2/Keap1 Pathway.

Qiu-Xu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.